$IOVA:21% Short. FDA Approved. Catalysts Ahead🚀🚀🚀
$IOVA
AI SUMMARY — IOVA has 21% short interest despite FDA approval, presenting a potential short squeeze opportunity with upcoming catalysts. The post suggests bullish sentiment due to the disconnect between approval status and short positioning, though execution risk remains on catalyst delivery.
| TICKER | IOVA |
USER | u/bumbarinap |
| RATING |
BULLISH |
ENTRY |
$11.00
|
| POSITION |
909 sh
SYN
|
BOOK VAL |
$10000.00 |
| CURRENT |
$10.99 |
P&L % |
-0.09%
|
| CURR VAL |
$9990.91 |
P&L $ |
-9.09
|